Clinuvel Pharmaceuticals Limited

CLVLY · OTC
Analyze with AI
$8.01−$0.14 (−1.72%)
At close:Dec 16, 2025, 9:00 PM UTC
$8.01+$0.00 (+0%)
After hours:Dec 16, 2025, 9:00 PM UTC
P/E TTM17.76
P/B TTM2.67
P/S TTM6.77
Dividend Yield0.39%
EPS$0.48
Beta0.917
Valuation
PEG Ratio-2.74
FCF Yield6.34%
EV / EBITDA8.91
Quality
ROIC12.56%
Gross Margin77.03%
Cash Conv. Ratio1.14
Growth
Revenue 3Y CAGR6.65%
FCF Growth29.61%
Safety
Net Debt / EBITDA-4.75
Interest Coverage0.00
Efficiency
Inventory Turnover2.47
Cash Conv. Cycle210.35

Clinuvel Pharmaceuticals Limited (CLVLY) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Clinuvel Pharmaceuticals Limited (CLVLY) stock price today?

As of Dec 16, 2025, 9:00 PM UTC, Clinuvel Pharmaceuticals Limited (CLVLY) stock is trading at $8.01. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date CLVLY stock quotes for informed trading decisions.

What is Clinuvel Pharmaceuticals Limited's market capitalization?

Clinuvel Pharmaceuticals Limited (CLVLY) has a market capitalization of approximately $402.1M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Clinuvel Pharmaceuticals Limited's size relative to other companies in the USD market. The market cap figure updates automatically as the CLVLY stock price changes.

What is the 52-week range for Clinuvel Pharmaceuticals Limited stock?

Clinuvel Pharmaceuticals Limited (CLVLY) stock has traded in a 52-week range of $6.00 — $9.00. The 52-week range shows the highest and lowest prices at which CLVLY traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Clinuvel Pharmaceuticals Limited stock price to this range provides context for recent price action.

How much trading volume does Clinuvel Pharmaceuticals Limited stock have?

Clinuvel Pharmaceuticals Limited (CLVLY) stock recently traded approximately 400 shares. Trading volume indicates market liquidity and investor interest in CLVLY. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Clinuvel Pharmaceuticals Limited stock.

Does Clinuvel Pharmaceuticals Limited pay dividends to shareholders?

Yes, Clinuvel Pharmaceuticals Limited (CLVLY) currently offers a dividend yield of approximately 0.39%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Clinuvel Pharmaceuticals Limited stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Clinuvel Pharmaceuticals Limited's intraday price range?

Today, Clinuvel Pharmaceuticals Limited (CLVLY) stock has traded in a range of $8.00 — $8.10. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring CLVLY's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Clinuvel Pharmaceuticals Limited stock data?

AlphaPilot sources real-time CLVLY stock quotes, fundamental financial data, and historical price charts for Clinuvel Pharmaceuticals Limited from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Clinuvel Pharmaceuticals Limited stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of CLVLY stock performance.